These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8245313)

  • 1. Clinical efficacy and side effects of acitretin on the disorders of keratinization: a one-year study.
    Kullavanijaya P; Kulthanan K
    J Dermatol; 1993 Aug; 20(8):501-6. PubMed ID: 8245313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An appraisal of acitretin therapy in children with inherited disorders of keratinization.
    Lacour M; Mehta-Nikhar B; Atherton DJ; Harper JI
    Br J Dermatol; 1996 Jun; 134(6):1023-9. PubMed ID: 8763418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinoids in psoriasis and disorders of keratinization.
    Fritsch PO
    J Am Acad Dermatol; 1992 Dec; 27(6 Pt 2):S8-14. PubMed ID: 1460124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral retinoid therapy for disorders of keratinization: single-centre retrospective 25 years' experience on 23 patients.
    Katugampola RP; Finlay AY
    Br J Dermatol; 2006 Feb; 154(2):267-76. PubMed ID: 16433796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acitretin.
    Ortiz NE; Nijhawan RI; Weinberg JM
    Dermatol Ther; 2013; 26(5):390-9. PubMed ID: 24099069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acitretin therapy in keratinization disorders].
    van Dooren-Greebe RJ; van de Kerkhof PC; Steijlen PM; Happle R
    Ned Tijdschr Geneeskd; 1990 Oct; 134(41):1995-2000. PubMed ID: 2146515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acitretin in the treatment of severe disorders of keratinization. Results of an open study.
    Blanchet-Bardon C; Nazzaro V; Rognin C; Geiger JM; Puissant A
    J Am Acad Dermatol; 1991 Jun; 24(6 Pt 1):982-6. PubMed ID: 1831211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical investigation of acitretin in children with severe inherited keratinization disorders in China.
    Zhang XB; Luo Q; Li CX; He YQ; Xu X
    J Dermatolog Treat; 2008; 19(4):221-8. PubMed ID: 18608715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of acitretin on the liver.
    Roenigk HH; Callen JP; Guzzo CA; Katz HI; Lowe N; Madison K; Nigra T; Fiedler VC; Armstrong RB
    J Am Acad Dermatol; 1999 Oct; 41(4):584-8. PubMed ID: 10495381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acitretin (Ro 10-1670, etretin): overall evaluation of clinical studies.
    Geiger JM; Czarnetzki BM
    Dermatologica; 1988; 176(4):182-90. PubMed ID: 2967779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind comparison of acitretin and etretinate in the treatment of severe psoriasis. Results of a Nordic multicentre study.
    Kragballe K; Jansén CT; Geiger JM; Bjerke JR; Falk ES; Gip L; Hjorth N; Lauharanta J; Mork NJ; Reunala T
    Acta Derm Venereol; 1989; 69(1):35-40. PubMed ID: 2563606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Side-effect profile of acitretin therapy in psoriasis.
    Gupta AK; Goldfarb MT; Ellis CN; Voorhees JJ
    J Am Acad Dermatol; 1989 Jun; 20(6):1088-93. PubMed ID: 2526824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of arsenical keratosis and Bowen's disease with acitretin.
    Yerebakan O; Ermis O; Yilmaz E; Basaran E
    Int J Dermatol; 2002 Feb; 41(2):84-7. PubMed ID: 11982642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and skeletal side effects of two years' acitretin treatment.
    Mørk NJ; Kolbenstvedt A; Austad J
    Acta Derm Venereol; 1992 Nov; 72(6):445-8. PubMed ID: 1362840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of acitretin in three fixed doses of 25, 35 and 50 mg in adult patients with severe plaque type psoriasis: a randomized, double blind, parallel group, dose ranging study.
    Dogra S; Jain A; Kanwar AJ
    J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):e305-11. PubMed ID: 22816881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Respiratory distress with acitretin, reversal by corticosteroid.
    Cuhadaroglu C; Korular D; Erelel M; Kiyan E; Kiliçaslan Z
    Dermatol Online J; 2001 Dec; 7(2):5. PubMed ID: 12165221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of systemic methotrexate vs. acitretin in psoriasis patients with significant palmoplantar involvement: a prospective, randomized study.
    Janagond AB; Kanwar AJ; Handa S
    J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):e384-9. PubMed ID: 23066720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acitretin improves psoriasis in a dose-dependent fashion.
    Goldfarb MT; Ellis CN; Gupta AK; Tincoff T; Hamilton TA; Voorhees JJ
    J Am Acad Dermatol; 1988 Apr; 18(4 Pt 1):655-62. PubMed ID: 2967310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-center retrospective study of long-term use of low-dose acitretin (Soriatane) for psoriasis.
    Lee E; Koo J
    J Dermatolog Treat; 2004 Jan; 15(1):8-13. PubMed ID: 14754643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The acitretin and methotrexate combination therapy for psoriasis vulgaris achieves higher effectiveness and less liver fibrosis.
    An J; Zhang D; Wu J; Li J; Teng X; Gao X; Li R; Wang X; Xia L; Xia Y
    Pharmacol Res; 2017 Jul; 121():158-168. PubMed ID: 28414177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.